QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avenue-therapeutics-q1-eps-1540-misses-900-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate o...

 avenue-therapeutics-may-offer-shares-of-common-stock-having-offering-price-of-up-to-39m-from-time-to-time-through-agent

- SEC Filing

 why-avenue-therapeutics-atxi-stock-is-falling-sharply

Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warran...

 why-avenue-therapeutics-atxi-shares-are-getting-hammered

Avenue Therapeutics shares are trading lower by 28.5% during Wednesday's session. The company is implementing a 1-for-75 re...

 avenue-therapeutics-plans-to-effect-1-for-75-reverse-split-of-its-issued-and-outstanding-common-stock

Avenue expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement ...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...